{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:38:55Z","timestamp":1786700335223,"version":"build-2736575974"},"reference-count":21,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,4,23]]},"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1136\/thorax-2026-225025","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:20:17Z","timestamp":1779297617000},"page":"819-820","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Making sense of azithromycin resistance patterns: what have we learnt and what should we do?"],"prefix":"10.1136","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2742-1836","authenticated-orcid":false,"given":"Will","family":"Carroll","sequence":"first","affiliation":[{"name":"Royal Stoke University Hospital, Academic Department of Child Health, Newcastle Road, Stoke-on-Trent, UK, ST4 6QG, Staffordshire Children\u2019s Hospital, Stoke-on-Trent, Staffordshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Chapman","sequence":"additional","affiliation":[{"name":"Academic Department of Child Health, Newcastle Road, ST4 6QG, Staffordshire Children\u2019s Hospital, Royal Stoke University Hospital, Stoke-on-Trent, Staffordshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1947-7621","authenticated-orcid":false,"given":"Francis J","family":"Gilchrist","sequence":"additional","affiliation":[{"name":"Academic Department of Child Health, Staffordshire Children\u2019s Hospital, Royal Stoke University Hospital, Stoke on Trent, UK"},{"name":"Institute of Applied Clinical Sciences, Keele University, Stoke on Trent, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"2026081402150643000_81.9.819.1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S2213-2600(24)00079-1","article-title":"Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial","volume":"12","author":"Lowe","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2026081402150643000_81.9.819.2","article-title":"Macrolide antibiotics (including azithromycin) for cystic fibrosis","volume":"2","author":"Southern","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"2026081402150643000_81.9.819.3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-2600(22)00165-5","article-title":"The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial","volume":"10","author":"Stick","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2026081402150643000_81.9.819.4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S2213-2600(20)30058-8","article-title":"Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial","volume":"8","author":"Kobbernagel","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026081402150643000_81.9.819.5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01381-2019","article-title":"Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis","volume":"54","author":"Hiles","year":"2019","journal-title":"Eur Respir J"},{"key":"2026081402150643000_81.9.819.6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216053","article-title":"Seasonal Azithromycin Use in Paediatric Protracted Bacterial Bronchitis Does Not Promote Antimicrobial Resistance but Does Modulate the Nasopharyngeal Microbiome","volume":"24","author":"Hardman","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026081402150643000_81.9.819.7","article-title":"Postinfectious Bronchiolitis Obliterans in Children: Diagnostic Workup and Therapeutic Options: A Workshop Report","volume":"2020","author":"Jerkic","year":"2020","journal-title":"Can Respir J"},{"key":"2026081402150643000_81.9.819.8","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207349"},{"key":"2026081402150643000_81.9.819.9","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-8-41","article-title":"Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study","volume":"8","author":"Ballard","year":"2007","journal-title":"Respir Res"},{"key":"2026081402150643000_81.9.819.10","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21352"},{"key":"2026081402150643000_81.9.819.11","doi-asserted-by":"crossref","unstructured":"Gharehbaghi MM , Peirovifar A , Ghojazadeh M , et al . Efficacy of azithromycin for prevention of bronchopulmonary dysplasia (BPD). Turk J Med Sci 2012;42. doi:10.3906\/sag-1107-18","DOI":"10.3906\/sag-1107-18"},{"key":"2026081402150643000_81.9.819.12","doi-asserted-by":"publisher","DOI":"10.1159\/000509462"},{"key":"2026081402150643000_81.9.819.13","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2019-318122"},{"key":"2026081402150643000_81.9.819.14","first-page":"67","article-title":"Azithromycin is the answer in paediatric respiratory medicine, but what was the question?","volume":"34","author":"Bush","year":"2020","journal-title":"Paediatr Respir Rev"},{"key":"2026081402150643000_81.9.819.15","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00102014"},{"key":"2026081402150643000_81.9.819.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2010.12.010"},{"key":"2026081402150643000_81.9.819.17","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12960","article-title":"The differential effects of azithromycin on the airway epithelium in vitro and in vivo","volume":"4","author":"Slater","year":"2016","journal-title":"Physiol Rep"},{"key":"2026081402150643000_81.9.819.18","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.5.1805-1812.2006"},{"key":"2026081402150643000_81.9.819.19","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41564-026-02285-8","article-title":"Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19","volume":"11","author":"Glascock","year":"2026","journal-title":"Nat Microbiol"},{"key":"2026081402150643000_81.9.819.20","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-224094"},{"key":"2026081402150643000_81.9.819.21","unstructured":"OpenPrescribing.net, EBM DataLab. University of Oxford; 2020. Available: https:\/\/openprescribing.net [Accessed 21 Mar 2026]."}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2026-225025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:15:34Z","timestamp":1786698934000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2026-225025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":21,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,8,14]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/thorax-2026-225025"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2026-225025","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}